NFKB1 and colitis: A recent study showed that dietary alanyl-glutamine supplementation can effectively down-regulate the expression of myd88, NF-κB and pro-inflammatory factor genes in hybrid grouper, inhibit the NF-κB signaling pathway, and enhance the immune barrier to defend against colitis [90].